BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Liu L, Tao S, Yao Y, Wang Y, Wei Q, Shao A, Deng Y. Parthanatos and its associated components: Promising therapeutic targets for cancer. Pharmacol Res 2021;163:105299. [PMID: 33171306 DOI: 10.1016/j.phrs.2020.105299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Catanzaro E, Canistro D, Pellicioni V, Vivarelli F, Fimognari C. Anticancer potential of allicin: A review. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Meszka I, Polanowska J, Xirodimas DP. Mixed in chains: NEDD8 polymers in the Protein Quality Control system. Semin Cell Dev Biol 2022:S1084-9521(22)00013-1. [PMID: 35078718 DOI: 10.1016/j.semcdb.2022.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang X, Wei W, Tan S, Guo L, Qiao S, Yao B, Wang Z. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer. World J Surg Oncol 2021;19:248. [PMID: 34419055 DOI: 10.1186/s12957-021-02335-x] [Reference Citation Analysis]
4 Liu L, Li J, Ke Y, Zeng X, Gao J, Ba X, Wang R. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis. Cell Mol Life Sci 2022;79:60. [PMID: 35000037 DOI: 10.1007/s00018-021-04109-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lv ZC, Li F, Wang L, Zhao QH, Gang GS, Wu Y, Miao YQ, Yuan P. Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension. Am J Mens Health 2021;15:15579883211029458. [PMID: 34190625 DOI: 10.1177/15579883211029458] [Reference Citation Analysis]
6 Song S, Xiao Z, Dekker FJ, Poelarends GJ, Melgert BN. Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04038-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lou J, Zhou Y, Feng Z, Ma M, Yao Y, Wang Y, Deng Y, Wu Y. Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management. Front Oncol 2020;10:616952. [PMID: 33665167 DOI: 10.3389/fonc.2020.616952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ribeiro DL, Tuttis K, Oliveira LCBD, Serpeloni JM, Gomes INF, Lengert AVH, Rocha CQD, Reis RM, Cólus IMDS, Antunes LMG. The Antitumoral/Antimetastatic Action of the Flavonoid Brachydin A in Metastatic Prostate Tumor Spheroids In Vitro Is Mediated by (Parthanatos) PARP-Related Cell Death. Pharmaceutics 2022;14:963. [DOI: 10.3390/pharmaceutics14050963] [Reference Citation Analysis]
9 Kumar V, Kumar A, Mir KUI, Yadav V, Chauhan SS. Pleiotropic role of PARP1: an overview. 3 Biotech 2022;12:3. [PMID: 34926116 DOI: 10.1007/s13205-021-03038-6] [Reference Citation Analysis]
10 Reber JM, Mangerich A. Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose). Nucleic Acids Res 2021:gkab618. [PMID: 34302489 DOI: 10.1093/nar/gkab618] [Reference Citation Analysis]
11 Tian C, Liu Y, Li Z, Zhu P, Zhao M. Mitochondria Related Cell Death Modalities and Disease. Front Cell Dev Biol 2022;10:832356. [DOI: 10.3389/fcell.2022.832356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]